Kiniksa Pharmaceuticals
KNSA
KNSA
125 hedge funds and large institutions have $444M invested in Kiniksa Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more capital invested
Capital invested by funds: $383M → $444M (+$61M)
0.51% more ownership
Funds ownership: 86.8% → 87.31% (+0.51%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
125
Holding in Top 10
–
Calls
$6.89M
Puts
$2.69M
Top Buyers
| 1 | +$13.2M | |
| 2 | +$4.6M | |
| 3 | +$3.66M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$2.99M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$2.96M |
Top Sellers
| 1 | -$27M | |
| 2 | -$8.99M | |
| 3 | -$4.44M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.16M |
| 5 |
Walleye Capital
New York
|
-$2.62M |